|
2021
|
Invention
|
Treatment or prophylaxis of proliferative conditions.
The invention relates to novel compounds f... |
|
2019
|
Invention
|
Cysteine labelling. The present invention relates to the production of activated biological molec... |
|
2017
|
Invention
|
Sik inhibitor for use in a method of treating an inflammatory and/or immune disorder. The present... |
|
|
Invention
|
Treatment or prophylaxis of proliferative conditions. The invention relates to novel compounds fo... |
|
2014
|
Invention
|
Medical apparatus and its visualisation. An ultrasonically actuated medical implement is used in ... |
|
|
Invention
|
Medical apparatus and its visualisation. The invention relates to improving medical interventions... |
|
2013
|
Invention
|
Biomarker for vascular endothelial function.
A method of determining the vascular endothelial fu... |
|
|
Invention
|
Biomarker for vascular endothelial function. A method of determining the vascular endothelial fun... |
|
|
Invention
|
P53 activating compounds. The present invention relates to compounds which activate the p53 respo... |
|
|
Invention
|
A sik inhibitor for use in a method of treating an inflammatory and/or immune disorder. The prese... |
|
|
Invention
|
Siglec-9 binding agents. The present invention relates to agents capable of binding sialic acid-b... |
|
2012
|
Invention
|
Selective glycosidase inhibitors.
The present invention provides glucoimidazole derivatives and ... |
|
|
Invention
|
Inhibitors against endosomal/lysosomal enzymes. The present invention relates to a multi-function... |
|
|
Invention
|
Cancer therapy.
The present invention relates to an improved assay for identifying compounds tha... |
|
|
Invention
|
Treatment or prophylaxis of proliferative conditions.
The disclosure relates to novel compounds ... |
|
2010
|
Invention
|
Aroyl thiourea derivatives. The invention provides compounds according to formula (I): (wherein X... |
|
|
Invention
|
Aroylthiourea and arylthiocarbonylurea derivatives. The invention provides compounds according to... |
|
|
Invention
|
Approximal imaging device. The invention relates to an intraoral approximal assessment device com... |
|
|
Invention
|
Treatment or prophylaxis of proliferative conditions. The invention relates to novel compou... |
|
|
Invention
|
Diagnosis and treatment of cell proliferation and differentiation disorders based on the fmn2 gen... |
|
2009
|
Invention
|
Pyrimidine derivatives and their pharmaceutical use. 1 is as defined herein, or a physiologically... |
|
|
Invention
|
Pyrimide derivatives and their pharmaceutical use. The invention provides a compound according to... |
|
|
Invention
|
Methods concerning ppar delta and antagonists thereof. Non-human animals which overexpress PPARd ... |
|
|
Invention
|
P53 tumor suppressor protein activating. The invention provides a compound of formula (I), wherei... |
|
|
Invention
|
Treatment of epithelial fragility disorders. The present invention provides compounds which modul... |
|
2008
|
Invention
|
Nano-particle dispersions. A process for the production of an aqueous dispersion of metal nano pa... |
|
|
Invention
|
Targeted modulation of gene expression.
The present invention relates to a method of modulating ... |
|
|
Invention
|
Modulation of rsk. The present invention relates to specific compounds for use in controlling inf... |
|
|
Invention
|
Targeted modulation of gene expression. The present invention relates to a method of modulating g... |
|
|
Invention
|
Method of treating learning impairment in down's syndrome subjects.
The present invention provid... |
|
|
Invention
|
Pyrimidine compounds for the treatment of cancer, septic shock and/or primary open angle glaucoma... |
|
2007
|
Invention
|
Manufacture of rimcazole.
The present invention relates to a process for preparing Rimcazole and... |
|
|
Invention
|
Improvements in relation to cancer therapy.
The present invention relates to an improved assay f... |
|
|
Invention
|
Prevention/treatment of ichthyosis vulgaris, atopy and other disorders. The present invention rel... |
|
2006
|
Invention
|
Filaggrin. The present invention relates to the identification of loss-of-function mutations in t... |
|
|
Invention
|
Singlec-9 binding agents.
The present invention relates to agents capable of binding sialic acid... |
|
|
Invention
|
Inhibitor compounds. The present invention relates to compounds and uses of compounds which inter... |
